Genistein a soy-derived phytoestrogen has various biological actions including a weak estrogenic effect and inhibition of tyrosine kinases. Data from animal and in vitro studies suggest a protective role of genistein regarding blood vessels.
Studies demonstrate that genistein has anti-atherogenic effects and inhibits proliferation of vascular endothelial and smooth muscle cells. Several human intervention studies suggest a beneficial effect on atherosclerosis, markers of cardiovascular risk, vasomotor tone, vascular endothelial function, and systemic arterial compliance.
Genistein also inhibits human platelet aggregation in vitro and decreases TNF-induced monocyte chemoattractant protein-1 secretion in human vascular endothelial cells.
Monocyte chemoattractant protein-1 is associated with early phase monocyte infiltration into the coronary vessels which eventually causes arteriosclerosis (medial thickening and fibrosis) of coronary arteries.
The adhesion of mononuclear cells (monocytes) and their infiltration into the blood vessel wall are crucial early arteriosclerotic events. Genisteins ability to slow or block this cellular activity helps lessen the development of blockage in coronary arteries during the early stage of coronary artery disease.
Source:
Genistein Acutely Stimulates Nitric Oxide Synthesis in Vascular Endothelial Cells by a Cyclic Adenosine 5'-Monophosphate-Dependent Mechanism. Dongmin Liu, Laurie L. Homan and Joseph S. Dillon
Endocrinology Vol. 145, No. 12 5532-5539
© 2004 by The Endocrine Society
Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis. Masamichi Koyanagi, MD
Circulation. 2000;102:2243.
© 2000 American Heart Association, Inc.



